MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Sells 409,669 Shares of Omega Healthcare Investors, Inc. $OHI

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lowered its position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 43.3% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 536,208 shares of the real estate investment trust's stock after selling 409,669 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned about 0.19% of Omega Healthcare Investors worth $20,419,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in OHI. Ameriprise Financial Inc. increased its holdings in Omega Healthcare Investors by 3.9% in the 4th quarter. Ameriprise Financial Inc. now owns 776,715 shares of the real estate investment trust's stock worth $29,398,000 after acquiring an additional 28,921 shares during the last quarter. Baird Financial Group Inc. increased its holdings in Omega Healthcare Investors by 0.8% in the 4th quarter. Baird Financial Group Inc. now owns 50,492 shares of the real estate investment trust's stock worth $1,911,000 after acquiring an additional 380 shares during the last quarter. Cetera Investment Advisers increased its holdings in Omega Healthcare Investors by 5.6% in the 4th quarter. Cetera Investment Advisers now owns 93,096 shares of the real estate investment trust's stock worth $3,524,000 after acquiring an additional 4,943 shares during the last quarter. Cresset Asset Management LLC purchased a new stake in Omega Healthcare Investors in the 4th quarter worth about $201,000. Finally, CoreCap Advisors LLC increased its holdings in Omega Healthcare Investors by 177.3% in the 4th quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust's stock worth $60,000 after acquiring an additional 1,009 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on OHI. Royal Bank Of Canada lifted their price objective on Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a "sector perform" rating in a report on Thursday, August 7th. Scotiabank lifted their price objective on Omega Healthcare Investors from $39.00 to $42.00 and gave the stock a "sector perform" rating in a report on Thursday, August 28th. Mizuho lifted their target price on Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a report on Thursday. Raymond James Financial reaffirmed an "outperform" rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Finally, Truist Financial lifted their target price on Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a report on Wednesday, September 3rd. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $43.75.

Omega Healthcare Investors Price Performance

Shares of OHI traded down $0.01 during trading hours on Friday, reaching $42.49. 1,550,013 shares of the company's stock traded hands, compared to its average volume of 1,686,146. The stock has a market cap of $12.53 billion, a PE ratio of 26.23, a price-to-earnings-growth ratio of 2.23 and a beta of 0.71. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The firm's 50 day simple moving average is $40.26 and its 200-day simple moving average is $38.23. Omega Healthcare Investors, Inc. has a 12 month low of $35.04 and a 12 month high of $44.42.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. The firm had revenue of $235.60 million during the quarter, compared to the consensus estimate of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company's revenue for the quarter was up 11.8% on a year-over-year basis. During the same quarter last year, the company posted $0.71 EPS. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Equities analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.3%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio (DPR) is 165.43%.

Insider Activity

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the sale, the director owned 18,654 shares in the company, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.50% of the company's stock.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.